Bacterin’s research, supported in part by the grant, aims to provide biologic products for soft tissue and wound repair in wounded military personnel and civilians. Mark Schallenberger, MS, is the principal investigator for the research project.
“We are extremely grateful for the financial support from the state of Montana. This funding will support our development initiatives within the field of regenerative medicine,” said Bacterin’s CEO Dan Goldberger.
More articles on devices:
Aurora Spine, MedAssets enter into contract
Stryker, Medtronic, Aurora Spine & more — 11 key notes
Zimmer net earnings up 7.9% ahead of Biomet acquisition completion — 10 points
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
